About me
Julie Gilmore, Ph.D. is Vice President and Global Head for Gateway Labs by Lilly. Gateway Labs by Lilly is designed to speed the discovery of innovative medicines through collaboration with biotech companies in key geographies including San Francisco and Boston.
Julie joined Eli Lilly after Julie completing her Doctorate in Membrane Biophysics from Purdue University and her Postdoctoral Fellowship in Drug Transport from Indiana University School of Medicine. During her 20+year career at Lilly, Julie has held several leadership and scientific positions across research and drug development, including Head of Information Sciences and Clinical Operations for Lilly Europe, Global Head of Scientific Communications, and most recently and prior to moving to San Francisco, Global Head of Portfolio Management for the Neurodegeneration and Pain Early Phase Portfolio. Julie sits on the Board of Directors for Mozart Therapeutics, IgGenix and Biocom California. She is passionate about her role as a mentor and advisor to several university graduate school programs.